![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/joe-jimenezs-fund-aditum-launches-its-10th-biotech-celexor-bio-with-autoimmune-drug-from-inmagene/
https://www.prnewswire.com/news-releases/lilly-completes-acquisition-of-versanis-bio-301899755.html
https://www.prnewswire.com/news-releases/versanis-bio-to-present-new-clinical-data-at-american-diabetes-association-83rd-scientific-sessions-301858731.html
https://www.prnewswire.com/news-releases/versanis-announces-initiation-of-the-believe-global-phase-2b-study-of-bimagrumab-as-a-novel-treatment-for-obesity-301720433.html
https://www.prnewswire.com/news-releases/versanis-presents-preclinical-data-demonstrating-the-potential-of-bimagrumab-as-a-novel-obesity-treatment-at-obesityweek-2022-301665807.html
https://www.prnewswire.com/news-releases/versanis-bio-announces-leadership-and-board-appointments-as-company-prepares-to-initiate-phase-2b-study-with-novel-approach-to-obesity-301589702.html